BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3827 related articles for article (PubMed ID: 7425670)

  • 1. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
    Halliday WJ; Maluish AE; Little JH; Davis NC
    Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
    Marti JH; Thomson DM
    Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic response in patients with melanoma of the skin].
    Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
    Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of leukocyte adherence by a 3 M potassium chloride extracts of human malignant melanoma.
    Ichiki AT; Quirin YP; Krauss S; Sonoda T
    Cancer Lett; 1981 Apr; 12(3):259-69. PubMed ID: 7020923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
    Shenouda G; Thomson DM
    Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
    Winter M; Nelson DS; Milton GW
    Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
    Dini MM; Lenzi L; Faiferman I
    Am J Reprod Immunol (1980); 1983 Jun; 3(4):188-90. PubMed ID: 6881415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
    Lieberman R; Wybran J; Epstein W
    Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma.
    Char DH; Jerome L; McCoy JL; Herberman RB
    Am J Ophthalmol; 1975 May; 79(5):812-6. PubMed ID: 1146943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
    Onji M
    Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thoracic duct cannulation: manipulation of tumor-specific blocking factors in a patient with malignant melanoma.
    Isbister WH; Noonan FP; Halliday WJ; Clunie GJ
    Cancer; 1975 May; 35(5):1465-71. PubMed ID: 1122496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunity in melanomalignome (author's transl)].
    Fritz J; Grond K; Tilz GP
    Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 192.